Fischer Medical Ventures' Q4 FY 2025-26 Quarterly Results

Result Summary

• Fischer Medical Ventures Ltd reported a 3.1% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Mar (Q4 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 100.8%.
• Its expenses for the quarter were up by 25.1% QoQ and 113.6% YoY.
• The net profit decreased 137.0% QoQ and decreased 643.5% YoY.
• The earnings per share (EPS) of Fischer Medical Ventures Ltd declined at 0.1 during Q4 FY 2025-26.

Financial Statments for Q4 FY 2025-26

---

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Company Overview

Fischer Medical Ventures Ltd operates in the healthcare sector, focusing on medical technology and services. The company specializes in the development and distribution of innovative medical devices and healthcare solutions designed to improve patient outcomes. Fischer Medical Ventures is known for its commitment to research and development, continuously seeking advancements in medical technology. As of the latest available data, there are no specific recent developments mentioned, but the company continues to be a key player in the medical devices industry.

Revenue

In Q4FY26, Fischer Medical Ventures Ltd reported a total income of ₹99.01 crores. This reflects a slight decrease of 3.1% from the previous quarter (Q3FY26), where the total income stood at ₹102.18 crores. However, when compared to the same quarter in the previous year (Q4FY25), the total income has more than doubled, showcasing a significant year-over-year growth of 100.8%, as it was ₹49.32 crores in Q4FY25. This indicates a substantial increase in revenue generation capacity over the year.

Profitability

The financial performance in terms of profitability for Q4FY26 showed challenges. The company reported a loss in profit before tax amounting to -₹2.25 crores, a notable decline from the profit of ₹21.25 crores in Q3FY26. Year-over-year, the profit before tax also decreased compared to ₹1.92 crores in Q4FY25. After accounting for taxes, the profit after tax registered a loss of -₹7.12 crores in Q4FY26, showing a significant decrease from a profit of ₹19.23 crores in the previous quarter and ₹1.31 crores in Q4FY25. The earnings per share also reflected this trend, falling to -₹0.10 from ₹0.29 in Q3FY26 and ₹0.09 in Q4FY25.

Operating Metrics

The company's total expenses for Q4FY26 were ₹101.27 crores, which marks a significant increase of 25.1% from the previous quarter's expenses of ₹80.94 crores. Comparing year-over-year, there's an even more pronounced increase of 113.6%, as total expenses in Q4FY25 were ₹47.41 crores. The tax outlay increased substantially, standing at ₹4.86 crores in Q4FY26, compared to ₹1.95 crores in Q3FY26 and ₹0.50 crores in Q4FY25, showing a dramatic increase both quarter-over-quarter and year-over-year. These changes in expenses and tax indicate shifts in the company's cost structure and tax liabilities over the period.